The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2016 | Key tips for using Twitter for hematologists
Michael Thompson, MD, PhD of the Aurora Health Care, Milwaukee, WI shares some key Twitter tips for hematologists. Some of the tips Dr Thompson gives include staying authentic, deciding on what kind of presence you would like to establish and providing full disclosure on any potential conflicts of interest. Dr Thompson also mentions that Twitter may not be right for everyone and suggests other formats such as blogging.
Recorded at the American Society of Oncology (ASCO) 2016 Annual Meeting held in Chicago, IL.
